Completed PHASE4 INTERVENTIONAL 1-arm NCT00438919

A Multi-center Post-Market Surveillance Registry (E-SELECT)

The e-SELECT Registry a MULTICENTER POST-MARKET SURVEILLANCE

Sponsor: Cordis US Corp.

Updated 7 times since 2017 Last updated: Dec 2, 2009 Started: May 31, 2006 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Artery Disease, this trial is completed. The trial is conducted by Cordis US Corp. and has accumulated 7 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Dec 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cordis US Corp.

Data source: Cordis US Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Meyrin, Switzerland